Recent Headlines
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that, further to its press release dated September 6, 2019, it has completed a non-brokered private placement offering comprised of approximately 2,750,000 unit (full story)
COV.VN: 2.100 (+0.310)
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it has re-priced its non-brokered private placement originally announced on August 1, 2019 (the "Offering"). The Offering is being re-priced in order to mo (full story)
COV.VN: 2.100 (+0.310)
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its third quarter fiscal 2019 results. (full story)
COV.VN: 2.100 (+0.310)
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that the Company intends to raise up to an aggregate of $6.3 million in one or more closings (the "Offering"). (full story)
COV.VN: 2.100 (+0.310)
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, wishes to provide the following corporate update: (full story)
COV.VN: 2.100 (+0.310)
Performance Comparison
Key Statistics
| Annual EPS | -0.280 |
|---|---|
| Dividend & Yield | -- (--) |
| P/E Ratio | N/A |
| Market Capitalization, $K | 52,558 |
| Weighted Alpha | -53.10 |
| Standard Deviation | +3.22 |
| Profit Margin | -0.18% |
| Beta | 4.157 |
Growth Rates
| YTD | -48.78% | |||
| 1-Year | -59.22% | |||
| 3-Year | +30.43% | |||
| 5-Year | +89.19% | |||
| 10-Year | +775.00% |